Performance evaluation of antigen test (iFlash-2019-nCoV Antigen®) for detection of SARS-CoV-2 virus in serum samples

Lina Mouna, Melek Manai Manai Bouokazi, Coralie KERESTEDJIAN-PALLIER,Anne‐Marie Roque‐Afonso,Christelle Vauloup‐Fellous

Authorea (Authorea)(2023)

引用 0|浏览0
暂无评分
摘要
Molecular assays from nasopharyngeal swabs are the current reference method to diagnose COVID-19. As an alternative, we evaluated the performance of the iFlash-2019-nCoV Antigen® (YHLO, Shenzhen, China), developed for SARS-CoV-2 N-antigen detection in serum samples. Specificity, determined on 50 pre-pandemic samples, was 100%. Overall sensitivity, evaluated on 40 sera from patients with RT-PCR confirmed infection, was 67.5%. However, sensitivity reached 73% in symptomatic patients, 80% in patients with high and medium nasopharyngeal (NP) viral loads (samples with Ct≤33) and, 90% in samples collected within the first week after symptoms onset. These sera were further analyzed with the COV-QUANTO® ELISA and COVID-VIRO® LFIA assays (AAZ, Boulogne-Billancourt, France). EIA Ag assays from Yhlo and AAZ had comparable performances, and both were more sensitive than the LFIA. These findings suggest that SARS-CoV-2 N-antigen detection in serum could be an alternative to PCR from NP swabs, at least early after onset of symptoms. Further studies are required to confirm these results.
更多
查看译文
关键词
antigen test,serum,virus,sars-cov
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络